Activation of cumulus cell SMAD2/3 and epidermal growth factor receptor pathways are involved in porcine oocyte-cumulus cell expansion and steroidogenesis

Mol Reprod Dev. 2011 Jun;78(6):391-402. doi: 10.1002/mrd.21312. Epub 2011 Apr 25.

Abstract

Several lines of evidence suggest that in mice the activation of SMAD2/3 signaling by oocyte secreted factors, together with epidermal growth factor receptor (EGFR) activation, is essential to induce cumulus expansion. Here we show that inhibition of EGFR kinase in follicle stimulating hormone (FSH)-stimulated porcine oocyte-cumulus cell complex (OCCs) strongly decreases hyaluronan (HA) synthesis and its retention in the matrix, as well as progesterone synthesis. Although porcine cumulus cells undergo expansion independently of oocytes, we use biochemical and gene expression analyses to show that they do require activation of SMAD2/3 for optimal stimulation of HA synthesis and proteins involved in the organization of this polymer in the expanded matrix. Furthermore, FSH-induced progesterone synthesis by porcine cumulus cells was increased by blocking SMAD2/3 activation. In conclusion, these results support the hypothesis that an FSH-EGF autocrine loop is active in porcine OCCs, and provide the first evidence that the SMAD2/3 signaling pathway is induced by paracrine/autocrine factors in porcine cumulus cells and is involved in the control of both cumulus expansion and steroidogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • C-Reactive Protein / metabolism
  • Cell Adhesion Molecules / antagonists & inhibitors
  • Cell Adhesion Molecules / metabolism
  • Cumulus Cells / metabolism*
  • Dioxoles / pharmacology
  • Epidermal Growth Factor / metabolism
  • ErbB Receptors / antagonists & inhibitors
  • ErbB Receptors / metabolism*
  • Female
  • Follicle Stimulating Hormone / metabolism
  • Gene Expression Regulation, Developmental / drug effects
  • Glucuronosyltransferase / antagonists & inhibitors
  • Glucuronosyltransferase / metabolism
  • Hyaluronic Acid / biosynthesis*
  • Isoquinolines / pharmacology*
  • Meiosis / drug effects
  • Mice
  • Oocytes / enzymology*
  • Oocytes / physiology
  • Progesterone / biosynthesis*
  • Pyridines / pharmacology*
  • Pyrroles / pharmacology*
  • Quinazolines / pharmacology
  • Serum Amyloid P-Component / metabolism
  • Signal Transduction / drug effects
  • Smad2 Protein / antagonists & inhibitors
  • Smad2 Protein / metabolism*
  • Smad3 Protein / antagonists & inhibitors
  • Smad3 Protein / metabolism*
  • Swine
  • Tyrphostins / pharmacology

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • 6,7-dimethyl-2-(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo(2,3-b)pyridin-3-yl-prop-2-enoyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
  • Benzamides
  • Cell Adhesion Molecules
  • Dioxoles
  • Isoquinolines
  • Pyridines
  • Pyrroles
  • Quinazolines
  • Serum Amyloid P-Component
  • Smad2 Protein
  • Smad3 Protein
  • Tyrphostins
  • PTX3 protein
  • RTKI cpd
  • Progesterone
  • Epidermal Growth Factor
  • Follicle Stimulating Hormone
  • Hyaluronic Acid
  • C-Reactive Protein
  • Glucuronosyltransferase
  • ErbB Receptors